MAJEROVA, Petra, Peter BARATH, Alena MICHALICOVA, Stanislav KATINA, Michal NOVAK and Andrej KOVAC. Changes of Cerebrospinal Fluid Peptides due to Tauopathy. Journal of Alzheimer’s Disease. Amsterdam: IOS Press, 2017, vol. 58, No 2, p. 507-519. ISSN 1387-2877. Available from: https://dx.doi.org/10.3233/JAD-170110.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Changes of Cerebrospinal Fluid Peptides due to Tauopathy
Authors MAJEROVA, Petra (703 Slovakia), Peter BARATH (703 Slovakia), Alena MICHALICOVA (703 Slovakia), Stanislav KATINA (703 Slovakia, guarantor, belonging to the institution), Michal NOVAK (703 Slovakia) and Andrej KOVAC (703 Slovakia).
Edition Journal of Alzheimer’s Disease, Amsterdam, IOS Press, 2017, 1387-2877.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10103 Statistics and probability
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.476
RIV identification code RIV/00216224:14310/17:00095001
Organization unit Faculty of Science
Doi http://dx.doi.org/10.3233/JAD-170110
UT WoS 000402994400018
Keywords in English Cerebrospinal fluid; LC-MALDI MS; peptidomics; rat model; tauopathy
Tags NZ, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Nicole Zrilić, učo 240776. Changed: 5/4/2018 09:47.
Abstract
Alzheimer’s disease (AD) and progressive supranuclear palsy are two common neurodegenerative tauopathies, and the most common cause of progressive brain dementia in elderly affecting more than 35 million people. The tauopathies are characterized by abnormal deposition of microtubule associated protein tau into intracellular neurofibrillary tangles composed mainly of the hyperphosphorylated form of the protein. The diagnosis of tauopathies is based on the presence of clinical features and pathological changes. Over the last decade, there has been an intensive search for novel biochemical markers for clinical diagnosis of AD and other tauopathies. In the present study, we used transgenic rat model for tauopathy expressing human truncated tau protein (aa 151–391/4R) to analyze the cerebrospinal fluid (CSF) peptidome using liquid chromatography – matrix assisted laser desorption/ionization mass spectrometry (LC-MALDI TOF/TOF). From 345 peptides, we identified a total of 175 proteins. Among them, 17 proteins were significantly altered in the CSF of transgenic rats. The following proteins were elevated in the CSF of transgenic rats when compared to the control animals: neurofilament light and medium chain, apolipoprotein E, gamma-synuclein, chromogranin A, reticulon-4, secretogranin-2, calsyntein-1 and -3, endothelin-3, neuroendocrine protein B72A, alpha-1-macroglobulin, and augurin. Interestingly most of the identified proteins were previously linked to AD and other tauopathies, indicating the significance of transgenic animals in biomarker validation.
Links
GA15-06991S, research and development projectName: Analýza funkcionálních dat a související témata
Investor: Czech Science Foundation
PrintDisplayed: 25/4/2024 09:41